EUVIMEDEUVIMED entdecken
Crossref

Phenazine‐1‐Carboxylic Acid Inhibits Ferroptosis by Stabilizing EHMT2

Xue Sun, Yang Chen, Chaoyi Xia iD, Chong Wei, Junyi Shao, Dingyao Wang, Zixuan Fan, Jingshu Min, Caiyun Fu, Xi Wang

The FASEB Journal · 15.11.2026 · 40 (21)

DOI: 10.1096/fj.202602470r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 29.10.2026. Verfasst von Xue Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated 903 Hospital of Zhejiang Sci-Tech University, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China. Hauptthemen laut MEDLINE: Ferroptosis, Histone-Lysine N-Methyltransferase, Phenazines. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Zhejiang Sci-Tech University (ZSTU), Zhejiang Provincial Excellent Funding for Postdoctoral Researchers, Zhejiang Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis is a regulated form of cell death driven by iron‐dependent lipid peroxidation and implicated in the pathogenesis of various diseases. Identifying ferroptosis inhibitors may therefore provide therapeutic opportunities for these disorders. Here, we identified phenazine‐1‐carboxylic acid (PCA) as a potent ferroptosis inhibitor through high‐throughput screening. Mechanistically, PCA reduced the accumulation of intracellular reactive oxygen species (ROS) and lipid ROS in part by stabilizing the protein level of euchromatic histone‐lysine N‐methyltransferase 2 (EHMT2). PCA also markedly alleviated cisplatin‐induced acute kidney injury (AKI) in mice. These findings identify a previously unrecognized ferroptosis‐suppressive function of PCA and support its further evaluation as a lead compound for ferroptosis‐associated diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisHistone-Lysine N-MethyltransferasePhenazinesAnimalsReactive Oxygen SpeciesMiceHumansLipid PeroxidationCisplatinMice, Inbred C57BLMale

Stichwörter der Autor:innen

AKIEHMT2ferroptosisphenazine‐1‐carboxylic acid

Substanzen

Reactive Oxygen SpeciesHistone-Lysine N-Methyltransferase1-phenazinecarboxylic acidCisplatinPhenazines

Autor:innen und Institutionen

  • The Affiliated 903 Hospital of Zhejiang Sci-Tech University, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
  • Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, Zhejiang Sci-Tech University, Hangzhou, China.
  • Zhejiang Provincial Key Laboratory of Drug Discovery and Development for Metabolic Diseases, Zhejiang Sci-Tech University, Hangzhou, China.
  • Department of Hematology and Oncology, The 903rd Hospital of the Joint Logistic Support Force, Hangzhou, China.

ORCID-Profile: Chaoyi Xia

Förderung

  • Zhejiang Sci-Tech University (ZSTU)
  • Zhejiang Provincial Excellent Funding for Postdoctoral Researchers
  • Zhejiang Provincial Natural Science Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

Sun, X., Chen, Y., Xia, C., Wei, C., Shao, J., Wang, D., Fan, Z., Min, J., Fu, C., & Wang, X. (2026). Phenazine‐1‐Carboxylic Acid Inhibits Ferroptosis by Stabilizing EHMT2. The FASEB Journal, 40(21). https://doi.org/10.1096/fj.202602470r

Vancouver

Sun X, Chen Y, Xia C, Wei C, Shao J, Wang D, et al. Phenazine‐1‐Carboxylic Acid Inhibits Ferroptosis by Stabilizing EHMT2. The FASEB Journal. 2026;40(21). doi:10.1096/fj.202602470r

BibTeX
@article{Sun2026,
  author = {Sun, Xue and Chen, Yang and Xia, Chaoyi and Wei, Chong and Shao, Junyi and Wang, Dingyao and Fan, Zixuan and Min, Jingshu and Fu, Caiyun and Wang, Xi},
  title = {Phenazine‐1‐Carboxylic Acid Inhibits Ferroptosis by Stabilizing EHMT2},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {21},
  doi = {10.1096/fj.202602470r}
}
Kostenlos starten →